Remove Clinical Trials Remove Compliance Remove Consumption Remove DEA
article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. Schedule I.

article thumbnail

FDA CBD Regulations Are On the Way (Sorta)

Canna Law Blog

Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). A multitude of states now allow CBD in food and drinks for consumption by humans and animals.

CBD 75
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

However, Delta 8-THC is explicitly listed on the DEA 7370 Controlled Substance list, so it’s hard to imagine the cases ending in any other way than saying Delta 8-THC should be regulated like cannabis. . . We already see products with Delta 8-THC submitted at the state compliance level in California.

article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. Only CBD products produced in compliance with the Farm Bill would be legal by federal law. This does not however, mean that all CBD products are now legal.